|1.||Aliev, O I: 3 articles (03/2005 - 01/2003)|
|2.||Plotnikov, M B: 2 articles (03/2003 - 01/2003)|
|3.||Vasiliev, A S: 2 articles (03/2003 - 01/2003)|
|4.||Maslov, M Ju: 2 articles (03/2003 - 01/2003)|
|5.||Tjukavkina, N A: 2 articles (03/2003 - 01/2003)|
|6.||Plotnikova, M B: 1 article (03/2005)|
|7.||Iamkin, a V: 1 article (03/2005)|
|8.||Tiukavkina, N A: 1 article (03/2005)|
|9.||Romanova, E P: 1 article (02/2004)|
|10.||Fedosova, N F: 1 article (02/2004)|
|1.||Brain Ischemia (Cerebral Ischemia)
03/01/2005 - "[Effects of acetylsalicylic acid and diquertin on platelet aggregation and hemorheological parameters in rats with cerebral ischemia]."
03/01/2003 - "On a model of chronic brain ischemia, which is accompanied by significant deterioration of the rheological properties of blood, it was shown that a therapy with a mixture of Diquertin and Ascorbic Acid decreases the expression of the high blood viscosity syndrome."
01/01/2003 - "In a model of the high blood viscosity syndrome, developed after myocardial infarction in rats, it was observed that a therapy of a combination of diquertin (20 mg/kg) and ascorbic acid (50 mg/kg) for a -period of 6 days, resulted in an improvement of haemorheological indices. "
01/01/2003 - "Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid."
|3.||Type 2 Diabetes Mellitus (MODY)
|1.||Ascorbic Acid (Vitamin C)
|2.||Aspirin (Acetylsalicylic Acid)